1 – 10 of 99
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Evaluation of the ACR/EULAR 2022 criteria for classification of ANCA-associated vasculitis in a population-based cohort from Sweden
(
- Contribution to journal › Article
-
Mark
EULAR recommendations for the management of ANCA-associated vasculitis : 2022 update
(
- Contribution to journal › Article
-
Mark
Data-driven subclassification of ANCA-associated vasculitis : model-based clustering of a federated international cohort
(
- Contribution to journal › Article
-
Mark
Thyroid disease in ANCA-associated vasculitis : a clinical and epidemiological study
(
- Contribution to journal › Article
-
Mark
Classification Criteria for ANCA Associated Vasculitis – Ready for Prime Time?
(
- Contribution to journal › Scientific review
-
Mark
Mortality Rate by Diagnosis in ANCA-Associated Vasculitis Across FAIRVASC Registries
2024) p.187-187(
- Contribution to conference › Abstract
-
Mark
Drug exposure and subsequent diagnosis with ANCA-associated vasculitis – A population-based case- control study
2024) p.191-191(
- Contribution to conference › Abstract
-
Mark
Apolipoproteins and the risk of giant cell arteritis—a nested case–control study
(
- Contribution to journal › Article
-
Mark
The HLA region in ANCA-associated vasculitis : characterisation of genetic associations in a Scandinavian patient population
(
- Contribution to journal › Article
-
Mark
Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden
(
- Contribution to journal › Article